Jan 7, 2020
NEW YORK–(BUSINESS WIRE)–Genosity Inc. announced today that it has partnered with Columbia University Irving Medical Center to investigate genetic factors associated with wild-type cardiac amyloidosis, a type of heart failure caused by the buildup of amyloid protein.Read More
Aug 20-22 2019, Washington, DC
Interested in learning about new data strategies and solutions available to clinical laboratories? Stop by for a Breakfast Discussion on Thursday, August 22nd, 7:30AM to hear Genosity’s President and CTO, Robert D. Daber, PhD, DABMG as he explores:
Feb 12 2019
BOULDER, Colo., Feb. 12, 2019 /PRNewswire/ — ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine, today announced that it has entered into a broad strategic collaboration with Genosity Inc., a biotechnology company that provides expertise, software and technical solutions to unlock the power of precision medicine by advancing genomics and facilitating collaborative research.Read More
Nov 1-3 2018, San Antonio, TX
Genosity will be exhibiting at the AMP annual meeting. Stop by our booth 1408 to find out about our new exciting products.
May 15-17, 2018
Genosity will be exhibiting at the Bio-IT meeting. Stop by our booth 308 to meet us and learn what we have to offer.